Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Ferric oxyhydroxide is an ingredient used to treat hyperphosphatemia in patients with renal failure or patients on dialysis. An antiferromagnetic material; constitutes the core of natural ferritin.
- Formula / weight
- FeHO2 · 88.851 g/mol (avg)
- Also known as
- Hydrated ferric oxide · Iron hydroxide oxide
Resolves to
Compound
Clinical / RWD
Structure
InChIKey
IEECXTSVVFWGSE-UHFFFAOYSA-MSMILES[OH-].[O--].[Fe+3]Transporters
What you can answer from here — as of July 07, 2026
Which companies are running trials of Ferric oxyhydroxide, in which indications and phases, and which of those programs are still active?